General MedicationsIONTOPHORESISGeneric
IONTOCAINE
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Standard Dose
0.01MG/ML;2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview IONTOCAINE is listed in Drugs@FDA under application 020530 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE; LIDOCAINE HYDROCHLORIDE Form and strength SOLUTION;IONTOPHORESIS - 0.01MG/ML;2% Sponsor IOMED Submission history Latest submission status date: 1995-12-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview IONTOCAINE is listed in Drugs@FDA under application 020530 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE; LIDOCAINE HYDROCHLORIDE Form and strength SOLUTION;IONTOPHORESIS - 0.01MG/ML;2% Sponsor IOMED Submission history Latest submission status date: 1995-12-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.